How should Cerus balance increasing the shelf life of INTERCEPT-treated platelets against potential impacts on treatment efficacy?

Introduction

Balancing the shelf life extension of INTERCEPT-treated platelets against potential impacts on treatment efficacy is a critical trade-off for Cerus. This scenario involves weighing the benefits of longer storage times against possible reductions in platelet functionality. I'll analyze this trade-off by examining product details, stakeholder impacts, metrics, and experimental approaches to inform a strategic recommendation.

Step 1

Clarifying Questions (3 minutes)

• Based on the current market demand, I'm thinking shelf life extension could significantly impact inventory management. Could you provide more context on the current shelf life and the proposed extension?

Why it matters: Helps quantify the potential impact on hospital operations and waste reduction. Expected answer: Current shelf life is 5-7 days, proposing extension to 10-14 days. Impact on approach: Longer extension would justify more extensive efficacy testing.

• Considering our business model, I assume this impacts our pricing strategy. How does shelf life extension align with our current revenue model and market positioning?

Why it matters: Helps understand the financial implications and competitive advantage. Expected answer: Longer shelf life could command premium pricing but may require additional regulatory approvals. Impact on approach: Would influence the balance between speed to market and comprehensive efficacy studies.

• From a user perspective, I'm curious about the primary concerns of healthcare providers regarding platelet efficacy. What are the key efficacy metrics they focus on?

Why it matters: Ensures we're addressing the most critical aspects of platelet functionality. Expected answer: Clotting ability, platelet count, and hemostatic function are primary concerns. Impact on approach: Would guide the selection of key performance indicators for efficacy testing.

• Regarding technical feasibility, what modifications to the INTERCEPT system would be required to achieve the desired shelf life extension?

Why it matters: Helps assess the complexity and resource requirements for implementation. Expected answer: Minimal changes required, mainly adjustments to the preservation solution. Impact on approach: Simpler modifications would allow for faster implementation and testing.

• Considering project timelines, how urgent is this initiative in relation to other product development priorities?

Why it matters: Helps allocate resources and set realistic expectations for stakeholders. Expected answer: High priority due to competitive pressures, aiming for implementation within 12-18 months. Impact on approach: Would influence the depth and duration of efficacy studies.